2Insel T R, Wang P S. Rethinking Mental Illness[ J]. JAMA, 2010, 303(19) : 1970 - 1971.
3Kocsis J H, Leon A C, Markowitz J C, et al. Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psycho- therapy, or their combination [ J ]. J Clin Psychiatry, 2009, 70 ( 3 ) : 354 - 361.
4Goto S, Terao T, Hoaki N, et al. Is serotonergic function associated with the antidepressant effects of modified-electreconvulsive therapy? [J]. J Affect Disord, 2012, 136(3) : 1062 -1066.
5Trivedi M H, Daly E J. Measurement-based care for refractory depres- sion : a clinical decision support model for clinical research and practice [J]. Drug Alcohol Depend, 2007, 88( Suppl 2) : S61 - S71.
6Gaynes B N, Rush A J, Trivedi M H, et al. Primary versus specialty care outcomes for depressed outpatients managed with measurement- based care: results from STAR * D[J]. J Gen Intern Meal, 2008, 23 (5) : 551 -560.
7Oller-Canet S, Fernandez-San-Martin M I, Garcia-Lecina R, et al. Do depressed patients comply with treatments prescribed?: a crass- sectional study of adherence to the antidepressant treatment[ J]. Actas Esp Psiquiatr, 2011, 39(5): 288-293.
8Serna M C, Cruz I, Real J, et al. Duration and adherence of antide- pressant treatment (2003 to 2007 ) based on prescription database [J]. Eur Psychiatry, 2010, 25(4) : 206 -213.
9Akerblad A C, Bengtsson F, von-Knorring L, et al. Response, remission and relapse in relation to adherence in primary care treat- ment of depression : a 2-year outcome study[ J]. Int Clin Psychophar- macol, 2006, 21(2) : 117 -124.
10Practice guideline for the treatment of patients with major depressive disorder (revision), American Psychiatric Association[ J]. Am J Psy- chiatry, 2000, 157(4 Suppl) : 1 -45.
